WKWerner Kempf

Werner Kempf

*This is an algorithmically generated author record based on publicly available information.

Werner Kempf has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Paediatric cutaneous lymphomas: a review and comparison with adult counterparts

    by W. Kempf, D. V. Kazakov, I. E. Belousova, C. Mitteldorf, K. Kerl

    Primary cutaneous lymphomas (CL) in children is rare. Only a few studies focused specifically on paediatric CL and therefore little is known whether primary CL in children are similar to or different from their adult counterparts with respect to the clinicopathological presentation, behaviour and prognosis. An extensive literature search using PubMed/MEDLINE from January 1995 through July 2014 was undertaken for articles reporting cases of paediatric CL. In addition, we identified 31 children with CL in our institutions. Mycosis fungoides and lymphomatoid papulosis are the two most prevalent lymphoma forms in children. A few entities of cutaneous lymphomas such as cutaneous diffuse large B‐cell lymphoma leg type, and Sézary syndrome have not been reported so far in children. Other lymphoma entities such as hydroa vacciniforme‐like lymphoma are mostly seen in certain geographic areas (Asia, Central and South America). In the paediatric population, low‐malignant indolent forms such as primary cutaneous marginal zone lymphoma and primary cutaneous follicle centre lymphoma are very rare, whereas the more aggressive forms of B‐cell lymphomas, precursor lymphoblastic lymphomas, and blastic plasmacytoid dendritic cell neoplasm are the most common forms in children, mostly involving the skin secondarily. Most paediatric lymphomas have similar clinicopathological features and course as their adults counterparts, particularly in the group of cutaneous T‐cell lymphomas. The spectrum of cutaneous B‐cell lymphomas in children significantly differs from the one in adults. Diagnostic work‐up and treatment of paediatric patients with lymphomas are best achieved in close collaboration with paediatric haematopathologists and oncologists.


  • Kutane Lymphome

    by W. Kempf, C. Mitteldorf


  • Loss of expression of 5‐hydroxymethylcytosine in CD30‐positive cutaneous lymphoproliferative disorders

    by Aieska De Souza, Marianne Tinguely, Madeleine Pfaltz, Daniel R. Burghart, Werner Kempf

    Background: The methylation of DNA at position 5 of cytosine, and the subsequent reduction in intracellular 5-hydroxymethylcytosine (5-hmC) levels, is a key epigenetic event in several cancers, including systemic lymphomas. However, no studies have analyzed this epigenetic marker in cutaneous lymphomas. Therefore, we aimed to analyze the expression of 5-hmC in cutaneous CD30-positive lymphoproliferative disorders and compare it with a control group composed of reactive infectious and inflammatory disorders with CD30-positive cells.\ud Methods: Retrospective case series study with immunohistochemical analysis using anti-CD30 and anti-5-hmC antibodies in control (n = 19), lymphomatoid papulosis (LyP) (n = 27) and primary cutaneous anaplastic large cell lymphoma (ALCL) (n = 14) specimens.\ud Results: Complete loss of 5-hmC nuclear staining by CD30+ cells was observed in 63% of LyP cases, 57% of ALCL cases and 0% of control cases.\ud Conclusions: The presence of 5-hmC+ and CD30+ lymphocytes was highly suggestive of a benign process. In contrast, loss of 5-hmC nuclear staining was highly suggestive of a lymphoproliferative disorder (ALCL or LyP). Under these circumstances, the use of 5-hmC staining can be a useful adjunctive tool for discriminating between neoplastic CD30+ lymphoproliferations and inflammatory/infectious simulators harboring reactive CD30+ cells


  • Primary cutaneous follicle center lymphoma with diffuse CD30 expression: A report of 4 cases of a rare variant

    by Werner Kempf, Dmitry V. Kazakov, Arno Rütten, Rudolf A. Rupec, Petr Talarcik, Veronika Ballová, Katrin Kerl, Reinhard Dummer, Stephan Lautenschlager, Dieter R. Zimmermann, et al.


  • Angioinvasive Lymphomatoid Papulosis

    by Werner Kempf, Dmitry V. Kazakov, Andreas Hürlimann, Katrin Kerl

    Lymphomatoid papulosis (LyP) is part of the spectrum of primary cutaneous CD30+ lymphoproliferative disorders. The disease manifests with self-healing papulonodular skin lesions and exhibits a broad range of histological features. Five different histological LyP types, referred to as types A to E, have been delineated. The angioinvasive type E is characterized by angiocentric and angiodestructive tumoral infiltrates of medium sized to large CD30+ atypical lymphocytes with nuclear pleomorphism. In the majority of the cases, the tumor cells express CD8. Because of its histological features and the immunophenotypic findings, this variant of LyP is particularly prone to be misinterpreted as an aggressive lymphoma. This review addresses the clinicopathologic features and differential diagnosis of LyP type E and emphasizes the role of clinicopathologic correlation in the diagnostic workup.

  • Expression of programmed death-1 (CD279) in primary cutaneous B-cell lymphomas with correlation to lymphoma entities and biological behaviour

    by C. Mitteldorf, M. Bieri, N. Wey, K. Kerl, J. Kamarachev, M. Pfaltz, H. Kutzner, G. Roncador, D. Tomasini, W. Kempf

    BACKGROUND: Programmed death-1 (PD-1/CD279) is a cell surface protein expressed in activated T-cells and in a subset of T lymphocytes including follicular helper T-cells (TFH ). The interaction between PD-1 and its ligands plays a role in immune response, but also in immune evasion of malignancies. In nodal follicular lymphoma, the number of intratumoral PD-1 positive lymphocytes is associated with overall survival.\ud OBJECTIVES: We investigated 28 cases of PCBCL including primary cutaneous follicle center lymphoma (PCFCL; n=10), primary cutaneous marginal zone lymphoma (PCMZL; n=10) and diffuse large B-cell lymphoma, leg type (DLBCL-LT; n=8) for the number and density of PD-1 positive cells.\ud METHODS: Immunohistochemical stainings were performed. We used a computerized morphometric analysis for evaluation. The results were correlated with the clinical outcome. To distinguish between activated T-cells and TFH we performed PD-1/bcl-6 double staining and compared these results with CXCL-13. A double staining for PD-1 and PAX-5 was added to investigate if the tumor cells were positive for PD-1.\ud RESULTS: The PD-1 positive cells represented tumor infiltrating T-cells (TIL). Only a little subset (on average 12%) was represented by TFH . Patients with DLBCL-LT had a significant lower number of PD-1 positive TILs than PCMZL (p = 0.012) and PCFCL (p = 0.002) or both groups together (p = 0.001). The difference between PCMZL and PCFCL did not reach significance (p = 0.074). The tumor-cells were negative for PD-1.\ud CONCLUSIONS: A higher number of PD-1 expressing cells was found in indolent PCMZL and PCFCL in contrast to DLBCL-LT. The PD-1 positive cells in our study do not only represent TFH , but also by other activated T-cells as a part of the tumor microenvironment. The tumor cells in all investigated types of PCBCL did not show aberrant PD-1 expression. This article is protected by copyright. All rights reserved


  • Unilesional follicular mycosis fungoides: report of two cases with progression to tumor stage and review of the literature

    by Werner Kempf, Dmitry V. Kazakov, Martin Schermesser, Stanislav A. Buechner, Laurent Parmentier, Anja Wysocki, Gabriele Palmedo, Peter Häusermann

    Mycosis fungoides (MF) is the most common type of cutaneous lymphoma and has protean clinicopathological manifestations. Follicular or folliculotropic MF (FMF) is a rare variant, which histopathologically is characterized by pronounced folliculotropism of neoplastic T cells, with or without follicular mucinosis, and clinically by an impaired prognosis compared to classic MF. In contrast, unilesional MF is a very rare variant with an excellent prognosis, with a single case of large‐cell transformation reported to date. The combination of folliculotropic and unilesional MF is very unusual, with only two cases reported to date. Here we report two patients with unilesional folliculotropic MF with progression to tumor stage in both patients. To the best of our knowledge, this is the first report on the disease evolution with large‐cell transformation and progression of unilesional FMF. Complete remission was achieved by local radiation therapy in both patients. The differential diagnoses, classification and implications for the treatment of unilesional FMF as well as the pertinent literature are discussed.


  • Pityriasis Lichenoides et Varioliformis Acuta With Numerous CD30+ Cells

    by Werner Kempf, Dmitry V. Kazakov, Gabriele Palmedo, Sylvie Fraitag, Leo Schaerer, Heinz Kutzner

    Pityriasis lichenoides comprises a clinicopathologic spectrum of cutaneous inflammatory disorders, with the 2 most common variants being pityriasis lichenoides et varioliformis acuta (PLEVA) and pityriasis lichenoides chronica. The aim of the study was to describe 13 cases of a unique PLEVA variant characterized in the conspicuous CD30 component and thus mimicking lymphomatoid papulosis (LyP), a condition currently classified in the spectrum of CD30 lymphoproliferative disorders. The cohort included 10 female and 3 male patients whose ages at diagnosis ranged from 7 to 89 years (mean 41 y; median 39 y). The clinical manifestation was that of PLEVA, with small erythematous macules quickly evolving into necrotic papules. No waxing and waning was seen on follow-up in any of the cases. Histopathologically, typical features of PLEVA were present, but an unusual finding was occurrence of a considerable number of CD30 small lymphocytes as detected immunohistochemically. Over half of the cases also displayed a large number of CD8 cells and showed coexpression of CD8 and CD30 in the intraepidermal and dermal component of the infiltrate. Of the 11 cases of PLEVA studied for T-cell receptor gene rearrangement, 6 evidenced a monoclonal T-cell population, and 5 were polyclonal. Parvovirus B19 (PVB19) DNA was identified in 4 of 10 cases investigated, and positive serology was observed for PVB19 in 2 patients, altogether suggesting that PVB19 is pathogenetically linked to PLEVA at least in a subset of cases. The presence of CD30 lymphocytes and CD8 lymphocytes would be consistent with an inflammatory antiviral response, as CD30, even atypically appearing lymphoid cells have been identified in some viral skin diseases. The main significance of the PLEVA variant is, however, its potential confusion with LyP or some cytotoxic lymphomas. Admittedly, the CD30 PLEVA variant described herein and LyP show considerable overlap if one takes into account all known variations of the 2 conditions recognized in recent years, thus suggesting that LyP and PLEVA may be much more biologically closely related entities than currently thought or can even occur on a clinicopathologic spectrum.